(lp0
S'Analyst Activity  Rodman &amp; Renshaw Raises Its Price Target On TearLab Corp ... Market Exclusive - Mar 10, 2017 Today, Rodman &amp; Renshaw raised its price target on TearLab Corp  to per share. There are 1 hold rating, 2 buy ratings, 1 strong buy rating on the stock.TearLab Corporation Reports Fourth Quarter and Year End 2016 Financial Results - Yahoo FinanceTearLab Corp  Releases Earnings Results, Beats Expectations By $0.09 EPS - Chaffey Breeze'
p1
aS'Why TearLab Corp. Shares Dipped Motley Fool - Nov 13, 2013 What: Shares of TearLab , an ophthalmic  medical device company focused on helping diagnose dry eye disease, dipped as much as 11% after the company reported its third-quarter earnings results.'
p2
aS'TearLab Corp  Upgraded to Hold at Zacks Investment Research The Cerbat Gem - 20 hours ago TearLab Corp logo Zacks Investment Research upgraded shares of TearLab Corp  from a sell rating to a hold rating in a report released on Thursday morning.The Rodman &amp; Renshaw Reaffirms Buy Rating for TearLab Corp  - Petro Global News 24TearLab Corp Forecasted to Post FY2017 Earnings of  Per Share  - BBNS'
p3
aS"TearLab Corporation Reports Third Quarter and September Year-To-Date 2016 ... GlobeNewswire  - Nov 7, 2016 SAN DIEGO, Nov. 07, 2016  -- TearLab Corporation    today reported its consolidated financial results for the third quarter and nine months ended September 30, 2016.TearLab's  CEO Seph Jensen on Q3 2016 Results - Earnings Call Transcript - Seeking Alpha"
p4
aS'TearLab Corp  Cut to Sell at Zacks Investment Research Chaffey Breeze - Mar 13, 2017 Zacks Investment Research lowered shares of TearLab Corp  from a hold rating to a sell rating in a research report report published on Wednesday morning.TearLab Corp  Issues Earnings Results, Beats Expectations By $0.09 EPS - The Cerbat GemThe TearLab Corp  Posts Quarterly Earnings Results, Beats Expectations ... - Petro Global News 24'
p5
aS'TearLab Corporation Comments on Shire plc FDA Approval of Xiidra ... GlobeNewswire  - Jul 12, 2016 SAN DIEGO, July 12, 2016  -- TearLab Corporation   , a company that develops and markets point of care ophthalmic in-vitro diagnostics, today recognized Shire plc on its recent&nbsp;...'
p6
aS'TearLab Corp  Forecasted to Earn Q1 2017 Earnings of  Per Share Chaffey Breeze - Mar 15, 2017 TearLab Corp logo TearLab Corp  - Investment analysts at Craig Hallum issued their Q1 2017 earnings per share estimates for shares of TearLab Corp in a research note issued on Monday. Craig Hallum analyst B. Bonello anticipates that&nbsp;...TearLab Corp  Downgraded to Sell at Zacks Investment Research - BNB Daily The TearLab Corp  Receives $20.00 Average PT from Brokerages - Petro Global News 24'
p7
aS'Calibrating the Trade: Watching Technicals on Shares of TearLab Corp  Baxter Review - 18 hours ago TearLab Corp  has a current 14-day RSI of 31.41, the 7-day is 26.36, and the 3-day is resting at31.9. The RSI, or Relative Strength Index is a widely used oscillating indicator among traders and investors.'
p8
aS"TearLab Corporation to Report Fourth Quarter and Full-year 2016 Financial ... GlobeNewswire  - Feb 21, 2017 TearLab Corporation  develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care.What Type of Consensus Opinions Analysts hold about TearLab Corporation's ... - Hot Stocks PointIn Volatile Markets Do Analysts Think You Should Buy TearLab Corporation ? - The De Soto Edge"
p9
aS"Why This Analyst Sees TearLab Shares Tripling Benzinga - Jul 12, 2016 Rodman &amp; Renshaw's Raghuram Selvaraju mentioned that TearLab Corp 's Osmolarity System for the diagnosis of dry eye disease  is the first and only objective DED diagnostic test in the U.S."
p10
a.